NTLA icon

Intellia Therapeutics

288 hedge funds and large institutions have $2.02B invested in Intellia Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 113 increasing their positions, 88 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

20% less capital invested

Capital invested by funds: $2.51B → $2.02B (-$497M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

32% less call options, than puts

Call options by funds: $18.7M | Put options by funds: $27.6M

Holders
288
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18.7M
Puts
$27.6M
Net Calls
Net Calls Change

Top Buyers

1 +$13.6M
2 +$13.2M
3 +$12.6M
4
BlackRock
BlackRock
New York
+$10.9M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$10.8M

Top Sellers

1 -$75.7M
2 -$9.23M
3 -$8.51M
4
Norges Bank
Norges Bank
Norway
-$8.36M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
-$7.68M
Name Holding Trade Value Shares
Change
Change in
Stake
201
$66.8K
202
$65K
203
$62.1K
204
$61K
205
$59.2K
206
$58.3K
207
$56.5K
208
$52.8K
209
$52.5K
210
$51.5K
211
$49K
212
$47K
213
$45.9K
214
$40.8K
215
$40.3K
216
$38.3K
217
$38.2K
218
$28K
219
$26.5K
220
$23.9K
221
$22.4K
222
$20K
223
$18.8K
224
$17.2K
225
$17K